Wound Healing, Repair & IBD
2015 Innovations Symposium | July 20-21, 2015 | Hyatt Embarcadero | San Francisco
The Kenneth Rainin Foundation’s annual Innovations Symposium brings together influential and collaborative researchers, and innovative and creative thinkers to work toward the common goal of curing Inflammatory Bowel Disease (IBD).
Created by the Foundation in 2012, the Symposium serves as a powerful nexus for diverse people, ideas and insights with the potential to transform IBD research. Join us for the 2015 Innovations Symposium: Wound Healing, Repair & IBD, and take part in setting new directions in the field of IBD research. We hope to see you in San Francisco in July!
- Early bird registration – save $75 through March 30, 2015.
- Call for Abstracts closes April 15, 2015.
- Travel Grants open to eligible students & post-doctoral fellows.
- Synergy Award, up to $300,000, available exclusively to attendees.
Stephen Hanauer, PhD
IBD Research: From Animal Models to Human Models
An international leader in the treatment of IBD and distinguished physician scientist, Stephen Hanauer serves as the Clifford Joseph Barborka Professor of Medicine and the medical director of the Digestive Disease Center at Northwestern University. Among his many honors, Dr. Hanauer received the AGA Fiterman Foundation Joseph B. Kirsner Award in Gastroenterology in 2001 and the Janssen Award for Clinical Excellence in 2004. He has served as a Member and Chair of the U.S. Food and Drug Administration Advisory Panel for Gastrointestinal Disorders and is a member and former-Chairman of the International Organization for IBD. Dr. Hanauer has authored hundreds of peer-reviewed journal articles, books and book chapters, abstracts, monographs, and editorials. Dr. Hanauer currently serves as Associate Editor (IBD) of Clinical Gastroenterology and Hepatology.
Linheng Li, PhD
Stowers Institute for Medical Research, University of Kansas Medical Center
Characterization of Stress Responsible Stem Cell in Intestines
Linheng Li investigates adult stem cells, their development and maintenance, and their microenviroment and associated signaling pathways. He has carried out research projects identifying hematopoietic stem cell niche and discovered the critical role of PTEN that distinguishes normal versus cancer stem cells in bone marrow and intestines. Dr. Li is involved with a number of international research organizations such as the Chinese Bio-Science Investigator Society, the International Scientific Advisory Council for Ministry of Sciences and Technology of China, and the International Society of Stem Cell Research Program Committee. He has been awarded many honors and fellowships.
Wenjun Ouyang, PhD
The Function of IL-22 in Mucosal Immunity
Wenjun Ouyang joined Genentech as a scientist in 2001, after studying signal transduction and transcriptional networks in T helper cell differentiation. He has been involved in the development of therapies to treat autoimmunity and cancer by targeting different cytokine pathways and T helper subsets. Dr. Ouyang’s research interest is understanding the crosstalk between immune system and non-immune organs in various diseases involved in inflammation such as autoimmune diseases, metabolic syndromes and cancer.
Zena Werb, PhD
University of California, San Francisco
Molecular Mechanisms Regulating Stem Cells in Tissue Regeneration
Zena Werb is an expert in the cell biology of cell adhesion, matrix metalloproteinases, extracellular matrix, inflammatory cells and the epithelial microenvironment in development and breast cancer. Dr. Werb’s focus has been on the molecular mechanisms involved in extracellular matrix remodeling and inflammatory cell function in mammary development and breast cancer. She has used and developed a variety of technologies ranging from molecular biology to genetically engineered mouse models to intravital microscopy and 3D culture models.
Thomas Wynn, PhD
National Institutes of Allergy and Infectious Diseases, NIH
Therapeutic Targeting of IL-13 Signaling in Inflammatory Bowel Disease and Fibrosis
Thomas Wynn is a Senior Investigator and Chief of the Immunopathogenesis Section of the Laboratory of Parasitic Disease and affiliated Program in Barrier Immunity and Repair, in the National Institute of Allergy and Infectious Diseases, NIH in Bethesda, MD. He is also the Scientific Director of the NIH-Oxford-Cambridge Scholars program, a doctoral training program for outstanding science students committed to biomedical research. His laboratory group uses a variety of in vivo model systems to study the immunological mechanisms that control chronic inflammation and fibrosis. Dr. Wynn was recently elected to fellowship in the American Academy of Microbiology and has received several prestigious awards and two Merit Awards from the National Institutes of Health.
Learn more about Kenneth Rainin Foundation Grantee Speakers
Countdown to 2015 Symposium